Treatment Strategies for ARID1A-Deficient Ovarian Clear Cell Carcinoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment Strategies for ARID1A-Deficient Ovarian Clear Cell Carcinoma
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 8, Pages 1769
Publisher
MDPI AG
Online
2021-04-07
DOI
10.3390/cancers13081769
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An expanded universe of cancer targets
- (2021) William C. Hahn et al. CELL
- Targeting BET Proteins BRD2 and BRD3 in Combination with PI3K-AKT Inhibition as a Therapeutic Strategy for Ovarian Clear Cell Carcinoma
- (2021) Shogo Shigeta et al. MOLECULAR CANCER THERAPEUTICS
- An acetyl-histone vulnerability in PI3K/AKT inhibition-resistant cancers is targetable by both BET and HDAC inhibitors
- (2021) Di Wu et al. Cell Reports
- Incidence of endometrioid and clear-cell ovarian cancer in histological proven endometriosis: the ENOCA population-based cohort study
- (2020) Marjolein Hermens et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Rethinking of treatment strategies and clinical management in ovarian clear cell carcinoma
- (2020) Kazuaki Takahashi et al. International Journal of Clinical Oncology
- Pan-cancer analysis of whole genomes
- (2020) NATURE
- Tazemetostat: First Approval
- (2020) Sheridan M. Hoy DRUGS
- The SWI/SNF complex in cancer — biology, biomarkers and therapy
- (2020) Priya Mittal et al. Nature Reviews Clinical Oncology
- SWI/SNF inactivation in the endometrial epithelium leads to loss of epithelial integrity
- (2020) Jake J Reske et al. HUMAN MOLECULAR GENETICS
- Diffuse Intratumoral Stromal Inflammation in Ovarian Clear Cell Carcinoma is Associated With Loss of Mismatch Repair Protein and High PD-L1 Expression
- (2020) Shih-Yao Lin et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Evaluation of SWI/SNF Protein Expression by Immunohistochemistry in Ovarian Clear Cell Carcinoma
- (2020) Jennifer A. Bennett et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial
- (2020) Franck Morschhauser et al. LANCET ONCOLOGY
- SWI/SNF-deficient malignancies of the female genital tract
- (2020) W. Glenn McCluggage et al. SEMINARS IN DIAGNOSTIC PATHOLOGY
- Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer
- (2019) Mary L. Disis et al. JAMA Oncology
- Trends and characteristics of epithelial ovarian cancer in Japan between 2002 and 2015: A JSGO–JSOG joint study
- (2019) Hiroko Machida et al. GYNECOLOGIC ONCOLOGY
- Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers
- (2019) Hideaki Ogiwara et al. CANCER CELL
- Antitumor Activity and Safety of Pembrolizumab in Patients with Advanced Recurrent Ovarian Cancer: Results from the Phase 2 KEYNOTE-100 Study
- (2019) U A Matulonis et al. ANNALS OF ONCOLOGY
- Survival Following Chemotherapy in Ovarian Clear Cell Carcinoma Is Not Associated with Pathological Misclassification of Tumor Histotype
- (2019) Masataka Takenaka et al. CLINICAL CANCER RESEARCH
- Efficacy of glutathione inhibitors for the treatment of ARID1A-deficient diffuse-type gastric cancers
- (2019) Mariko Sasaki et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Low-dose triple drug combination targeting the PI3K/AKT/mTOR pathway and the MAPK pathway is an effective approach in ovarian clear cell carcinoma
- (2019) Joseph J. Caumanns et al. CANCER LETTERS
- ARID1A and PI3-kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion
- (2019) Mike R. Wilson et al. Nature Communications
- Therapeutic preferability of gemcitabine for ARID1A-deficient ovarian clear cell carcinoma
- (2019) Takafumi Kuroda et al. GYNECOLOGIC ONCOLOGY
- Analysis of gene expression signatures identifies prognostic and functionally distinct ovarian clear cell carcinoma subtypes
- (2019) Tuan Zea Tan et al. EBioMedicine
- ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade
- (2018) Jianfeng Shen et al. NATURE MEDICINE
- ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors
- (2018) Katrien Berns et al. ONCOGENE
- Histone deacetylase 6 in cancer
- (2018) Ting Li et al. Journal of Hematology & Oncology
- Clonal Expansion and Diversification of Cancer-Associated Mutations in Endometriosis and Normal Endometrium
- (2018) Kazuaki Suda et al. Cell Reports
- Characterization and drug sensitivity of a novel human ovarian clear cell carcinoma cell line genomically and phenotypically similar to the original tumor
- (2018) Miriam Franklin et al. Cancer Medicine
- Modular Organization and Assembly of SWI/SNF Family Chromatin Remodeling Complexes
- (2018) Nazar Mashtalir et al. CELL
- Recent Progress in Histone Deacetylase Inhibitors as Anticancer Agents
- (2018) Loredana Cappellacci et al. CURRENT MEDICINAL CHEMISTRY
- Immunohistochemistry expression of targeted therapies biomarkers in ovarian clear cell and endometrioid carcinomas (type I) and endometriosis
- (2018) Amilcar Barreta et al. HUMAN PATHOLOGY
- Integrated Genomic, Epigenomic, and Expression Analyses of Ovarian Cancer Cell Lines
- (2018) Eniko Papp et al. Cell Reports
- Identification of somatic genetic alterations in ovarian clear cell carcinoma with next generation sequencing
- (2017) Yusuke Shibuya et al. GENES CHROMOSOMES & CANCER
- Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference
- (2017) Ji Yon Agnes Jang et al. Journal of Gynecologic Oncology
- Clinical statistics of gynecologic cancers in Japan
- (2017) Wataru Yamagami et al. Journal of Gynecologic Oncology
- Mismatch repair status and PD-L1 expression in clear cell carcinomas of the ovary and endometrium
- (2017) Brian C Willis et al. MODERN PATHOLOGY
- ARID1A-mutated ovarian cancers depend on HDAC6 activity
- (2017) Benjamin G. Bitler et al. NATURE CELL BIOLOGY
- Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
- (2017) Ahmet Zehir et al. NATURE MEDICINE
- Cancer-Associated Mutations in Endometriosis without Cancer
- (2017) Michael S. Anglesio et al. NEW ENGLAND JOURNAL OF MEDICINE
- AACR Project GENIE: Powering Precision Medicine through an International Consortium
- (2017) Cancer Discovery
- Clear cell ovarian cancers with microsatellite instability: A unique subset of ovarian cancers with increased tumor-infiltrating lymphocytes and PD-1/PD-L1 expression
- (2017) Brooke E. Howitt et al. OncoImmunology
- Mismatch Repair Protein Expression in Clear Cell Carcinoma of the Ovary
- (2016) Jennifer A. Bennett et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial
- (2016) Toru Sugiyama et al. JOURNAL OF CLINICAL ONCOLOGY
- Clear cell carcinoma of the ovary: molecular insights and future therapeutic perspectives
- (2016) Seiji Mabuchi et al. Journal of Gynecologic Oncology
- ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A
- (2016) Chris T. Williamson et al. Nature Communications
- Comprehensive assessment of the expression of the SWI/SNF complex defines two distinct prognostic subtypes of ovarian clear cell carcinoma
- (2016) Hisham Abou-Taleb et al. Oncotarget
- Loss of ARID1A expression leads to sensitivity to ROS-inducing agent elesclomol in gynecologic cancer cells
- (2016) Suet-Yan Kwan et al. Oncotarget
- Polycomb and trithorax opposition in development and disease
- (2016) Steven T. Poynter et al. Wiley Interdisciplinary Reviews-Developmental Biology
- Phase I study of combination of vorinostat, carboplatin, and gemcitabine in women with recurrent, platinum-sensitive epithelial ovarian, fallopian tube, or peritoneal cancer
- (2015) Ursula Matulonis et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Safety and Antitumor Activity of Anti–PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer
- (2015) Junzo Hamanishi et al. JOURNAL OF CLINICAL ONCOLOGY
- Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden
- (2015) Michael S Anglesio et al. JOURNAL OF PATHOLOGY
- Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers
- (2015) Benjamin G Bitler et al. NATURE MEDICINE
- Coexistent ARID1A–PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling
- (2015) Ronald L. Chandler et al. Nature Communications
- ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors
- (2015) J. Shen et al. Cancer Discovery
- Gynecologic Cancer InterGroup (GCIG) Consensus Review for Clear Cell Carcinoma of the Ovary
- (2014) Aikou Okamoto et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial
- (2014) Jonathan Ledermann et al. LANCET ONCOLOGY
- Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4
- (2014) Pilar Ramos et al. NATURE GENETICS
- Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type
- (2014) Leora Witkowski et al. NATURE GENETICS
- Cumulative Haploinsufficiency and Triplosensitivity Drive Aneuploidy Patterns and Shape the Cancer Genome
- (2013) Teresa Davoli et al. CELL
- Increased Incidence of Severe Gastrointestinal Events With First-Line Paclitaxel, Carboplatin, and Vorinostat Chemotherapy for Advanced-Stage Epithelial Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
- (2013) Alberto A. Mendivil et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Inactivating Mutations in SWI/SNF Chromatin Remodeling Genes in Human Cancer
- (2013) Takahiro Oike et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy
- (2013) Cigall Kadoch et al. NATURE GENETICS
- The Spectrum of SWI/SNF Mutations, Ubiquitous in Human Cancers
- (2013) A. Hunter Shain et al. PLoS One
- Phase II Activity of Belinostat (PXD-101), Carboplatin, and Paclitaxel in Women With Previously Treated Ovarian Cancer
- (2012) Don S. Dizon et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Clear cell carcinoma of the ovary: A report from the first Ovarian Clear Cell Symposium, June 24th, 2010
- (2011) Michael S. Anglesio et al. GYNECOLOGIC ONCOLOGY
- Salvage chemotherapy for recurrent or persistent clear cell carcinoma of the ovary: a single-institution experience for a series of 20 patients
- (2011) Kiyoshi Yoshino et al. International Journal of Clinical Oncology
- Epigenetic Antagonism between Polycomb and SWI/SNF Complexes during Oncogenic Transformation
- (2010) Boris G. Wilson et al. CANCER CELL
- Differences in Tumor Type in Low-stage Versus High-stage Ovarian Carcinomas
- (2010) Martin Köbel et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Clinicopathological Significance of Loss of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma
- (2010) Daichi Maeda et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- ARID1AMutations in Endometriosis-Associated Ovarian Carcinomas
- (2010) Kimberly C. Wiegand et al. NEW ENGLAND JOURNAL OF MEDICINE
- Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
- (2010) Siân Jones et al. SCIENCE
- PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core Domain
- (2009) Jeremy M.R. Lambert et al. CANCER CELL
- Endometrioid and clear cell ovarian cancers – A comparative analysis of risk factors
- (2008) Christina M. Nagle et al. EUROPEAN JOURNAL OF CANCER
- A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study
- (2008) Susan C. Modesitt et al. GYNECOLOGIC ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now